Twenty-five health groups signed on to a letter to the Trump administration, urging that FDA be exempted from the requirement to submit proposed rules for review by Congress and the administration.
Don’t try to convince Col. Susan Fondy that lymphedema doesn’t merit interest from medical researchers.
